Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 89851-89900 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT05198635
Association Between Local Cerebral Oxygenation Monitoring and Postoperative Delirium in Carotid Endarterectomy
N/A
Recruiting
140 participants
Started: Feb 14, 2022 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT05085340
MULTIple Doses of IPTi Proposal: a Lifesaving High Yield Intervention
N/A
Active, not recruiting
94,252 participants
Started: Feb 14, 2022 · Completed: Oct 31, 2025
1 condition
6 sponsors
3 locations
NCT05199376
Evaluation of Percutaneous Cryotherapy in the Treatment of Plexiform Neurofibromas and Unresectable Neurofibromas in Neurofibromatosis Type 1
NA
Recruiting
30 participants
Started: Feb 14, 2022 · Completed: Feb 7, 2027
2 conditions
1 sponsor
1 location
NCT05077709
IO102-IO103 in Combination With Pembrolizumab as First-line Treatment for Patients With Metastatic NSCLC, SCCHN, or mUBC
PHASE2
Active, not recruiting
63 participants
Started: Feb 14, 2022 · Completed: Nov 30, 2024
3 conditions
5 sponsors
21 locations
NCT05311488
Early Detection of Neuropathy in ATTRv
N/A
Active, not recruiting
47 participants
Started: Feb 14, 2022 · Completed: Feb 14, 2029
1 condition
3 sponsors
1 location
NCT05604963
Hemithyroidectomy or Total-Thyroidectomy in 'Low-risk' Thyroid Cancers
NA
Recruiting
456 participants
Started: Feb 14, 2022 · Completed: Jul 31, 2031
1 condition
2 sponsors
35 locations
NCT05232240
Blood Pressure Variability in Non-hypertensive Patients With Ischemic Cerebrovascular Disease
N/A
Recruiting
300 participants
Started: Feb 14, 2022 · Completed: Feb 29, 2028
2 conditions
1 sponsor
1 location
NCT05266625
Digital Therapeutic Based Investigation to Improve Glycemic Control in Patients With Type 2 Diabetes and Residual Hyperglycemia on Stable Medical Therapy
NA
Active, not recruiting
500 participants
Started: Feb 14, 2022 · Completed: Nov 30, 2025
1 condition
6 sponsors
3 locations
NCT05240547
Chiropractic Spinal Manipulation for Headache
NA
Recruiting
20 participants
Started: Feb 14, 2022 · Completed: Dec 14, 2024
2 conditions
1 sponsor
1 location
NCT05084833
ASPIRES (Activating Cancer Survivors and Their Primary Care Providers to Increase Colorectal Cancer Screening) Study
NA
Active, not recruiting
300 participants
Started: Feb 14, 2022 · Completed: Nov 1, 2025
2 conditions
9 sponsors
4 locations
NCT04573023
A Phase III Study of JR-141 in Patients With Mucopolysaccharidosis II (STARLIGHT)
PHASE3
Active, not recruiting
86 participants
Started: Feb 14, 2022 · Completed: Oct 31, 2027
1 condition
1 sponsor
29 locations
NCT05272345
Fibromyalgia and Sexual Functıonal Dısorder and Sexual Therapy
NA
Active, not recruiting
30 participants
Started: Feb 14, 2022 · Completed: Dec 14, 2025
2 conditions
1 sponsor
2 locations
NCT05995067
The Potential Association of Long Non-coding RNA (NEAT1 and MALAT1) in the Process of Epithelial-mesenchymal Transition in Periodontitis
N/A
Active, not recruiting
48 participants
Started: Feb 14, 2022 · Completed: Jan 30, 2024
3 conditions
1 sponsor
1 location
NCT04911478
Long-term Follow-up Study of Allogeneic Gamma Delta (γδ) CAR T Cells
N/A
Enrolling by invitation
50 participants
Started: Feb 14, 2022 · Completed: Aug 31, 2039
6 conditions
1 sponsor
5 locations
NCT05262491
A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumor and Other Solid Tumor
PHASE1
Recruiting
96 participants
Started: Feb 14, 2022 · Completed: Dec 31, 2027
1 condition
3 sponsors
6 locations
NCT05091905
Patient-Titrated Automated Intermittent Boluses of Local Anesthetic vs. a Continuous Infusion Via a Perineural Catheter for Postoperative Analgesia
PHASE4
Enrolling by invitation
140 participants
Started: Feb 14, 2022 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT05166161
A Long-Term Safety Study of PTC923 in Participants With Phenylketonuria
PHASE3
Recruiting
200 participants
Started: Feb 14, 2022 · Completed: Apr 30, 2026
1 condition
1 sponsor
45 locations
NCT05383274
Optilume PoST AppRoval Clinical Evaluation of Andrology ParaMeters
PHASE4
Recruiting
34 participants
Started: Feb 14, 2022 · Completed: Dec 30, 2026
1 condition
2 sponsors
9 locations
NCT06242041
The Effect of Potassium Lowering Drugs on Cardiac Electrical Stability in Hemodialysis Patients (ART Study)
PHASE4
Recruiting
61 participants
Started: Feb 14, 2022 · Completed: Dec 31, 2024
3 conditions
1 sponsor
1 location
NCT05823623
Inetetamab Combined With Pyrotinib Plus Oral Vinorelbine for the Treatment of HER2-positive Metastatic Breast Cancer
PHASE2
Recruiting
30 participants
Started: Feb 13, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT04848896
Study to Evaluate the Safety and Effectiveness of the REAL INTELLIGENCE™ CORI™ in Total Knee Arthroplasty (TKA) Procedure
NA
Recruiting
140 participants
Started: Feb 12, 2022 · Completed: May 15, 2027
3 conditions
1 sponsor
4 locations
NCT05141721
A Study of a Patient-Specific Neoantigen Vaccine in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal Cancer
PHASE2/PHASE3
Active, not recruiting
700 participants
Started: Feb 12, 2022 · Completed: Mar 31, 2027
1 condition
1 sponsor
43 locations
NCT06570733
Acceptability Research on Integrated Point of Care Sexually Transmitted Infection (STI) Testing and Expedited Partner Therapy (EPT)
N/A
Active, not recruiting
305 participants
Started: Feb 11, 2022 · Completed: Dec 31, 2024
3 conditions
2 sponsors
1 location
NCT05269316
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
PHASE1/PHASE2
Recruiting
61 participants
Started: Feb 11, 2022 · Completed: Dec 31, 2026
2 conditions
1 sponsor
8 locations
NCT05209100
Microbiome-Mediated Gut Dysfunction in Non-Alcoholic Fatty Liver Disease
N/A
Active, not recruiting
38 participants
Started: Feb 11, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05040308
Uganda PrEP and Harm Reduction Evaluation
NA
Active, not recruiting
300 participants
Started: Feb 11, 2022 · Completed: Dec 31, 2025
1 condition
3 sponsors
1 location
NCT04984343
Randomized Trial of Five or Two MRI-Guided Adaptive Radiotherapy Treatments for Prostate Cancer
PHASE2
Active, not recruiting
33 participants
Started: Feb 11, 2022 · Completed: Dec 31, 2028
1 condition
3 sponsors
2 locations
NCT04998669
Loncastuximab Tesirine in Combination With Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma
PHASE2
Recruiting
100 participants
Started: Feb 11, 2022 · Completed: Aug 1, 2030
1 condition
2 sponsors
5 locations
NCT02669797
Family Matters Intervention
NA
Enrolling by invitation
500 participants
Started: Feb 11, 2022 · Completed: Apr 30, 2028
2 conditions
4 sponsors
2 locations
NCT04924985
Goal-directed CPR Using Cerebral Oximetry
NA
Active, not recruiting
150 participants
Started: Feb 11, 2022 · Completed: Jul 31, 2025
2 conditions
2 sponsors
1 location
NCT05214885
Novel Biomarkers of Hypoxia and Metabolism in Clear Cell Renal Cell Carcinoma
N/A
Recruiting
300 participants
Started: Feb 11, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT06378632
AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM
N/A
Recruiting
500 participants
Started: Feb 11, 2022 · Completed: Jul 15, 2025
1 condition
1 sponsor
45 locations
NCT05368974
"The Treatment in Pregnancy for Hepatitis C (TiP-HepC) Registry"
N/A
Recruiting
100 participants
Started: Feb 11, 2022 · Completed: Dec 30, 2026
1 condition
2 sponsors
1 location
NCT05196867
Liver Cancer Prevention Randomized Control Trial
NA
Active, not recruiting
49 participants
Started: Feb 11, 2022 · Completed: Aug 30, 2025
3 conditions
2 sponsors
1 location
NCT04823741
Molecular, Pathologic Intra Tumoral Heterogeneity in Malignant Pleural Mesothelioma
N/A
Recruiting
30 participants
Started: Feb 11, 2022 · Completed: Feb 11, 2026
3 conditions
1 sponsor
1 location
NCT04417166
Pembrolizumab and Radiotherapy for Patients With NK/T Cell Lymphoma
PHASE2
Recruiting
30 participants
Started: Feb 11, 2022 · Completed: Dec 31, 2026
1 condition
2 sponsors
2 locations
NCT05283200
Creating a Healthy L.I.F.E: Lifestyle Interventions For Epilepsy
NA
Active, not recruiting
1,000 participants
Started: Feb 11, 2022 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT05031780
A Study Evaluating the Efficacy and Safety of Mitapivat (AG-348) in Participants With Sickle Cell Disease (RISE UP)
PHASE2/PHASE3
Active, not recruiting
286 participants
Started: Feb 11, 2022 · Completed: Feb 28, 2030
1 condition
1 sponsor
90 locations
NCT05246813
Metabolic Profiling of Hematopoietic Stem Cells in Clonal Hematopoiesis (CHIP)
N/A
Recruiting
24 participants
Started: Feb 11, 2022 · Completed: Dec 31, 2025
5 conditions
2 sponsors
1 location
NCT05056922
Telehealth Rapid Intervention for Externalizing Behaviors in ASD
NA
Enrolling by invitation
80 participants
Started: Feb 11, 2022 · Completed: Oct 31, 2025
5 conditions
2 sponsors
1 location
NCT05217641
A Clinical Trial to Evaluate the Safety and Immunogenicity of BG505 MD39.3, BG505 MD39.3 gp151, and BG505 MD39.3 gp151 CD4KO HIV Trimer mRNA Vaccines in Healthy, HIV-uninfected Adult Participants
PHASE1
Active, not recruiting
108 participants
Started: Feb 11, 2022 · Completed: Jun 24, 2027
1 condition
3 sponsors
10 locations
NCT05080309
Effect of Oral Carbohydrate Intake > 44kCal Per Hour During Labour on the Rate of Instrumental Vaginal Delivery
NA
Recruiting
600 participants
Started: Feb 11, 2022 · Completed: Sep 3, 2028
3 conditions
1 sponsor
1 location
NCT05066607
Isatuximab Plus Pomalidomide and Dexamethasone Association for Patients With AL Amyloidosis Not in VGPR or Better After Any Previous Therapy
PHASE2
Recruiting
46 participants
Started: Feb 11, 2022 · Completed: Mar 31, 2026
1 condition
3 sponsors
15 locations
NCT04789057
Atorvastatin Effect on Reduction of COPD Exacerbations
PHASE4
Recruiting
460 participants
Started: Feb 11, 2022 · Completed: May 31, 2027
5 conditions
2 sponsors
1 location
NCT04230148
Study of Safety, Tolerability and Clinical Outcomes of Egaten in Fascioliasis Patients (6 Years of Age or Older).
PHASE4
Recruiting
300 participants
Started: Feb 11, 2022 · Completed: Dec 10, 2026
1 condition
1 sponsor
10 locations
NCT04772235
Phase I Study of Repotrectinib and Osimertinib in NSCLC Patients
PHASE1
Recruiting
32 participants
Started: Feb 11, 2022 · Completed: Jun 30, 2026
1 condition
2 sponsors
4 locations
NCT07160478
Effectiveness of Health Education Program on Musculoskeletal Pain Management in Primary School Students
NA
Active, not recruiting
82 participants
Started: Feb 10, 2022 · Completed: Jan 31, 2026
6 conditions
1 sponsor
1 location
NCT05309759
Impact of Undernutrition Definitions on Its Prevalence in Hospitalized Patients
N/A
Recruiting
260 participants
Started: Feb 10, 2022 · Completed: Dec 10, 2025
1 condition
1 sponsor
1 location
NCT06934330
Effect of Tao Calligraphy Meditation and Energized Water on Depression
NA
Recruiting
50 participants
Started: Feb 10, 2022 · Completed: Jan 10, 2027
1 condition
1 sponsor
1 location
NCT05170984
MAtrix Therapy for Hard-to-heal ChrOnic Wounds
NA
Recruiting
200 participants
Started: Feb 10, 2022 · Completed: Jul 31, 2024
4 conditions
1 sponsor
1 location
Previous
1
More pages
1795
1796
1797
1798
1799
1800
1801
More pages
2369
Next